Internal Medicine, Gastroenterology · Pensacola, FL
NPI
1568559938
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4531 N Davis Hwy
Pensacola, FL, 32503
Phone (850) 436-4563
Groups this clinician bills Medicare through
Medicare paid, 2024
$275K
9,447 services
Medicare patients, 2024
647
Average age 73
Drug cost, 2024
$1.4M
1,028 prescriptions
Company payments, 2025
$623
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick F Reilly was code J3380 (injection, vedolizumab, intravenous, 1 mg), 6,600 times for 11 patients. In total Patrick F Reilly billed 9,447 services in 59 codes, and Medicare paid $275K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 6,600 | 11 | $17.50 | $115K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,090 | 11 | $25.00 | $27K |
| 43239 Upper GI Endoscopy | Facility | 230 | 222 | $80.39 | $18K |
| 45385 Colonoscopy - Lesion Removal | Facility | 174 | 174 | $202.68 | $35K |
| 45380 Lower GI Endoscopy - Other | Facility | 167 | 167 | $69.29 | $12K |
| 99214 Office E&M - Established | Office | 105 | 87 | $88.94 | $9,339 |
| 99232 Hospital E&M - Subsequent | Facility | 96 | 63 | $61.30 | $5,885 |
| 99222 Hospital E&M - Initial | Facility | 79 | 79 | $101.45 | $8,015 |
| 43450 Digestive/Gastrointestinal | Facility | 62 | 61 | $30.50 | $1,891 |
| 99231 Hospital E&M - Subsequent | Facility | 31 | 27 | $38.77 | $1,202 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 27 | 27 | $179.85 | $4,856 |
| 45378 Lower GI Endoscopy - Other | Facility | 24 | 23 | $127.73 | $3,066 |
| 96413 Chemotherapy Administration | Office | 23 | 13 | $92.11 | $2,118 |
| 96365 Intravenous Infusion, Hydration | Office | 23 | 12 | $46.87 | $1,078 |
| 99204 Office E&M - New | Office | 17 | 17 | $118.52 | $2,015 |
By year: 2022 $231K for 7,816 services; 2023 $263K for 9,064 services; 2024 $275K for 9,447 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patrick F Reilly prescribed most often to Medicare patients was Pantoprazole Sodium, with 151 prescriptions and refills. In total Patrick F Reilly wrote 1,028 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 151 | 395 | 61 | $1,640 |
| Omeprazole Generic | 132 | 303 | 40 | $2,054 |
| Promethazine Hcl Generic | 90 | 96 | Under 11 | $4,756 |
| Esomeprazole Magnesium Generic | 62 | 106 | 14 | $1,459 |
| Famotidine Generic | 43 | 113 | 17 | $453 |
| Dextrose In Lactated Ringers Dextrose 5%-Lactated Ringers | 34 | 34 | Under 11 | $521 |
| Metoclopramide Hcl Generic | 33 | 43 | Under 11 | $967 |
| Stelara Ustekinumab | 29 | 50 | Under 11 | $839K |
| Dicyclomine Hcl Generic | 29 | 51 | 11 | $592 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 27 | 31 | Under 11 | $818 |
| Creon Lipase/Protease/Amylase | 27 | 45 | Under 11 | $147K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 22 | 22 | 22 | $353 |
| Linzess Linaclotide | 22 | 52 | Under 11 | $28K |
| Colesevelam Hcl Generic | 21 | 42 | Under 11 | $3,373 |
| Sucralfate Generic | 19 | 43 | Under 11 | $1,293 |
Brand drugs: - claims; generic drugs: 796 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick F Reilly $623 ($623 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $144.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $144 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $115 |
| Madrigal Pharmaceuticals MDGL | 2 | $74.26 |
| Janssen Biotech, Inc. JNJ | 3 | $66.79 |
| Pfizer Inc. PFE | 4 | $60.84 |
| Lilly USA, LLC LLY | 3 | $54.45 |
| Genzyme Corporation SNY | 2 | $44.45 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $36.98 |
| Ardelyx, Inc. ARDX | 1 | $13.58 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $12.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.